The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Open accessAbstract
Major histocompatibility complex (MHC)-restricted cytotoxic T lymphocytes (CTL) are part of the cellular immune response to human persistent virus infections. Measurements of the frequency and specificity of human immunodeficiency virus type 1 (HIV-1)-specific CTL and their variation with time may indicate their relative importance in modulating the progression of HIV-1 infection. We have used limiting dilution analysis (LDA) to derive quantitative estimates of the frequency of HIV-1-specific CTL precursors in a cross-sectional study of 23 patients at different clinical stages of HIV-1 infection and to compare these with the frequency of CTL precursors specific for another persistent virus (Epstein-Barr virus [EBV]) in the same patients. Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with autologous HIV-1-infected lymphoblasts and assayed for cytotoxicity in 51Cr release assays against autologous and MHC-mismatched lymphoblastoid B cells infected with recombinant vaccinia viruses expressing the three HIV-1 structural gene products. The frequency of MHC-restricted precursors was high in asymptomatic HIV-1-infected patients (env-specific CTL precursors up to 73/10(6) PBMC; gag-specific CTL precursors up to 488/10(6) PBMC), although the relative frequency against the different structural gene products varied from patient to patient. The HIV-1-specific CTL precursor frequency was reduced in patients who had more severe (< 400/microliters) CD4+ lymphocyte depletion, while in the majority of such patients the frequency of CTL precursors against EBV was maintained at levels observed in healthy controls. Direct CTL activity in unstimulated PBMC was observed in three of nine patients but no correlation was found between the presence of an activated CTL response and the magnitude of the CTL response detected after stimulation in LDA. Thus, CTL precursors were detected against all three HIV-1 structural gene products in patients with CD4+ lymphocyte counts > 400/microliters, at frequencies that are high compared with those reported for other persistent viruses. A CTL response directed against multiple protein antigens of HIV-1 may protect the patient against epitope variation. The fact that the EBV-specific CTL precursor frequencies were maintained in advanced HIV-1 infection suggests that there may be selective impairment of the HIV-1-specific CTL response associated with disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R. M., Rizza, C. R., et al. (1991) · Nature · doi:10.1038/354453a0 · Cited by 1,015
CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
Walker, C. M., Moody, D. J., Stites, D. P., & Levy, J. A. (1986) · Science · doi:10.1126/science.2431484 · Cited by 990
Cytotoxic T-Cell Immunity to Influenza
McMichael, A. J., Gotch, F. M., Noble, G. R., & Beare, P. A. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307073090103 · Cited by 927
Reusser, P., Riddell, Sr., Meyers, J., & Greenberg, P. (1991) · Blood · doi:10.1182/blood.v78.5.1373.1373 · Cited by 666
Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations
Meyerhans, A., Cheynier, R., Albert, J., Seth, M., Kwok, S., Sninsky, J., Morfeldt-Månson, L., Asjö, B., & Wain-Hobson, S. (1989) · Cell · doi:10.1016/0092-8674(89)90942-2 · Cited by 651
Reddehase, M. J., Mutter, W., Münch, K., Bühring, H. J., & Koszinowski, U. H. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3102-3108.1987 · Cited by 423
Lindahl, K. F., & Wilson, D. B. (1977) · The Journal of experimental medicine · doi:10.1084/jem.145.3.508 · Cited by 358
Lin, Y. L., & Askonas, B. A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.2.225 · Cited by 342
Limiting Dilution Analysis of Cells in the Immune System
Thompson, R. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.6.607-a · Cited by 324
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.
Hoffenbach, A., Langlade-Demoyen, P., Dadaglio, G., Vilmer, E., Michel, F., Mayaud, C., Autran, B., & Plata, F. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.452 · Cited by 304
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals.
Macatonia, S. E., Lau, R., Patterson, S., Pinching, A. J., & Knight, S. C. (1990) · PubMed · Cited by 271
Borysiewicz, L. K., Hickling, J. K., Graham, S., Sinclair, J., Cranage, M. P., Smith, G. L., & Sissons, J. G. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.3.919 · Cited by 246
Self-citationRyser, J. E., & MacDonald, H. R. (1979) · PubMed · Cited by 132
Johnson, R. P., Piechocka‐Trocha, A., Buchanan, T. M., & Walker, B. D. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.961 · Cited by 132
Koenig, S., Earl, P. L., Powell, D., Pantaleo, G., Merli, S., Moss, B., & Fauci, A. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.22.8638 · Cited by 128
Cytotoxic T-cell recognition of HIV proteins and peptides.
Nixon, D. F., & McMichael, A. J. (1991) · PubMed · Cited by 116
Gotch, F., Nixon, D. F., Alp, N., McMichael, A. J., & Boryslewicz, L. K. (1990) · International Immunology · doi:10.1093/intimm/2.8.707 · Cited by 108
Koup, R., Pikora, C., Luzuriaga, K., Brettler, D. B., Day, E. S., Mazzara, G. P., & Sullivan, J. L. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1593 · Cited by 106
VII International Conference on AIDS
Wallace, B., & Lasker, J. S. (1991) · Aids Patient Care · doi:10.1089/apc.1991.5.233 · Cited by 99
Fishwild, D. M., Benike, C. J., & Engleman, E. G. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.6.1994 · Cited by 22
Cited by
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Mathematical Analysis of HIV-1 Dynamics in Vivo
Perelson, A. S., & Nelson, P. W. (1999) · SIAM Review · doi:10.1137/s0036144598335107 · Cited by 1,552
Jin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Self-citation
Metadata
- Authors
- Carmichael, A., Jin, X., Sissons, P., & Borysiewicz, L.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-02-01
- Volume
- 177
- Issue
- 2
- Pages
- 249-256
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2071459721
- Cited by
- 418
- References
- 20
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.